Company profile
Diag-Nose.io
Mapping the unified airway to discover lifesaving medicines and deliver breakthrough respiratory care.
- Industry
- Biotechnology Research
- Employees
- 20
- Headquarters
- Melbourne, VIC
- Founded
- 2020
- LinkedIn followers
- 1,478
- Office locations
- 3
Diag-Nose.io company summary
Diag-Nose.io is a company in the Biotechnology Research industry, headquartered in Melbourne, VIC, founded in 2020. On LinkedIn the company has around 20 employees and 1,478 followers. The company lists 3 office locations.
What technology does Diag-Nose.io use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Diag-Nose.io
Diag-Nose.io, founded in 2020 and headquartered in Melbourne, Australia, is a biotechnology company focused on translating the complexities of the unified airway into precision diagnostic and drug discovery solutions. Their precision medicine technology combines advanced proteomics, computational biology, and AI (machine learning) to create a scalable respiratory biology model. This innovation aims to help clinicians prescribe the right treatments faster and enable researchers to accelerate the development of new therapies. The company’s flagship platform, RhinoMAP™, leverages proteomic data to predict respiratory disease activity, monitor therapy response and predict treatment efficacy in advance, with an initial focus on anti-Th2 biologics.
Where is Diag-Nose.io located?
Diag-Nose.io lists 3 office locations.
Compare companies similar to Diag-Nose.io
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Diag-Nose.io diag-nose.io | Biotechnology Research | 20 | 2020 | Melbourne, VIC |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Diag-Nose.io
What does Diag-Nose.io do?
Diag-Nose.io, founded in 2020 and headquartered in Melbourne, Australia, is a biotechnology company focused on translating the complexities of the unified airway into precision diagnostic and drug discovery solutions. Their precision medicine technology combines advanced proteomics, computational biology, and AI (machine learning) to create a scalable respiratory biology model. This innovation aims to help clinicians prescribe the right treatments faster and enable researchers to accelerate the development of new therapies. The company’s flagship platform, RhinoMAP™, leverages proteomic data to predict respiratory disease activity, monitor therapy response and predict treatment efficacy in advance, with an initial focus on anti-Th2 biologics.
How many employees does Diag-Nose.io have?
Diag-Nose.io has around 20 employees on LinkedIn.
Where is Diag-Nose.io headquartered?
Diag-Nose.io is headquartered in Melbourne, VIC.
Where does Diag-Nose.io have offices?
Diag-Nose.io lists 3 office locations, including Melbourne, VIC, AU; Bethlehem, Pennsylvania, US; Houston, Texas, US.
When was Diag-Nose.io founded?
Diag-Nose.io was founded in 2020.
Build a lead list from companies like Diag-Nose.io
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.